TGI-5

TGI-5 · Hefei TG ImmunoPharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TGI-5, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors [Phase 1]

See pricing